ABSTRACT
Background: Our aim is to evaluate the possible persistence of lung parenchyma alterations, in patients who have recovered from Covid-19.
Design and methods: We enrolled a cohort of 115 patients affected by Covid-19, who performed a chest CT scan in the Emergency Department and a chest CT 18 months after hospital discharge. We performed a comparison between chest CT scan 18 months after discharge and spirometric data of patients enrolled. We obtained quantitative scores related to well-aerated parenchyma, interstitial lung disease and parenchymal consolidation. A radiologist recorded the characteristics indicated by the Fleischner Society and “fibrotic like” changes, expressed through a CT severity score ranging from 0 (no involvement) to 25 (maximum involvement).
Results: 115 patients (78 men, 37 women; mean age 60.15 years old ±12.52). On quantitative analysis, after 18 months, the volume of normal ventilated parenchyma was significantly increased (16.34 points on average ±14.54, p<0.0001). Ground-glass opacities and consolidation values tend to decrease (-9.80 and -6.67 points, p<0.0001). On semiquantitative analysis, pneumonia extension, reactive lymph nodes and crazy paving reached statistical significance (p<0.0001). The severity score decreased by 2.77 points on average (SD 4.96; p<0.0001). There were not statistically significant changes on “fibrotic-like” changes correlated with level of treatment and there was not a statistically significant correlation between CT lung score and spirometric results obtained 18 months after discharge.
Conclusions: Patients recovered from Covid-19 seem to have an improvement of ventilated parenchyma and “fibrotic-like” alterations. The level of treatment does not appear to influence fibrotic changes.
REFERENCES
World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from: who.int/emergencies/diseases/novel-coronavirus-2019
Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 2020;63:457-60. DOI: https://doi.org/10.1007/s11427-020-1637-5
Myall KJ. Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 inflammatory interstitial lung disease: an observational study of corticosteroid treatment. Ann Am Thorac Soc 2021;18:799-806. DOI: https://doi.org/10.1513/AnnalsATS.202008-1002OC
Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology 2008;246:697-722. DOI: https://doi.org/10.1148/radiol.2462070712
Wells AU, Devaraj A, Desai SR. Interstitial lung disease after COVID-19 infection: A catalog of uncertainties. Radiology 2021;299:e216-8. DOI: https://doi.org/10.1148/radiol.2021204482
Han X, Cao Y, Jiang N, et al. Novel coronavirus pneumonia (COVID-19) progression course in 17 discharged patients: Comparison of clinical and thin-section CT features during recovery. Clin Infect Dis 2020;71:723-31.
Han X, Fan Y, Alwalid O, et al. Six-months follow-up chest CT findings after severe COVID-19 pneumonia. Radiology 2021;299:e177-86. DOI: https://doi.org/10.1148/radiol.2021203153
Pan F, Yang L, Liang B, et al. Chest CT patterns from diagnosis to 1 year of follow-up in COVID-19. Radiology 2022;302:709-19. DOI: https://doi.org/10.1148/radiol.2021211199
Alarcón-Rodríguez J, Fernández-Velilla M, Ureña-Vacas A, et al. [Manejo y seguimiento radiológico del paciente post-COVID-19].[Article in Spanish]. Radiologia 2021;63:258-69. DOI: https://doi.org/10.1016/j.rx.2021.02.003
Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 2012;30:1323-41. DOI: https://doi.org/10.1016/j.mri.2012.05.001
Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA – Secondary Publication. J Thorac Imaging 2020;35:219-27. DOI: https://doi.org/10.1097/RTI.0000000000000524
Pan F, Ye T, Sun P, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020;295:715-21. DOI: https://doi.org/10.1148/radiol.2020200370
Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 2020;25:100463. DOI: https://doi.org/10.1016/j.eclinm.2020.100463
Han X, Cao Y, Jiang N, et al. Novel coronavirus disease 2019 (COVID-19) pneumonia progression course in 17 discharged patients: Comparison of clinical and thin-section computed tomography features during recovery. Clin Infect Dis 2020;71:723-31. DOI: https://doi.org/10.1093/cid/ciaa271